|2006||Res-Del International Ltd was renamed Aqix Limited following new investment funding and a new corporate board. Res-Del International Ltd was the incorporation of Res-Del Ltd, New Zealand.|
|2003||Patent for RS-I solution granted in EU/USA for organ perfusion and preservation. Solution receives AQIX® trademark.|
|2002-2005||Res-Del Ltd negotiated with a Organ Recovery Systems and Bowman Research (USA) to audit trial AQIX® RS-I solution for use as a hypothermic preservation and normothermic perfusion medium with human tissues and organs.
These trials proved successful with AQIX® RS-I being adopted as the data base perfusate in drug bioassay assessment of re-animated cadaver human donor organs (e.g., kidneys; lungs; livers; intestine) which were unsuitable for recipient transplantation.
|2000||Res-Del International Ltd files patent on RS-I solution for examination in EU/USA.|